For the Inventor, By the Inventor

Enter assignee name

New Delhi, India

Ranbaxy Laboratories, Inc.

USPTO Granted Patents = 157

% Expired Patents = 62.4

EPO Patents = 28

Trademarks = 6

Forward Citations = 461

Loading Chart...

Loading Chart...

253 inventors (with patents filed for the assignee):

Yatendra Kumar (36 out of 37 patents)

Mohan Prasad (30 out of 43 patents)

Anita Mehta (21 out of 23 patents)

4. Rajesh Kumar Thaper (16 out of 17 patents)

5. Jag Mohan Khanna (15 out of 15 patents)

6. Jang Bahadur Gupta (14 out of 15 patents)

7. Naresh Kumar (13 out of 27 patents)

8. Swargam Sathyanarayana (11 out of 12 patents)

9. Mahavir Singh Khanna (9 out of 13 patents)

10. Abhijit Ray (9 out of 9 patents)

11. Mohammad Salman (9 out of 12 patents)

12. Himadri Sen (9 out of 9 patents)

13. Sudershan Kumar Arora (8 out of 17 patents)

14. Venkata Poornapragnacharyulu Palle (8 out of 106 patents)

15. Sanjay Kumar Jain (7 out of 26 patents)

Core Competencies:

Pharmaceutical Compositions

Crystalline Forms

Stable Formulations

Dabigatran Etexilate

Tigecycline

Dexlansoprazole

Antimicrobial Agents

Matrix Metalloproteinase Inhibitors

Antimalarials

Phosphodiesterase Inhibitors

HMG-CoA Reductase Inhibitors

Muscarinic Receptor Antagonists

157 patents: Sort by Forward Citations

1. 9150542 - Process for the preparation of crystalline form I of methanesulfonate salt of dabigatran etexilate (2015-10-06),

2. 9145421 - Process for the preparation of asenapine maleate (2015-09-29),

3. 9132092 - Pharmaceutical composition of doxycycline (2015-09-15),

4. 9107929 - Stable parenteral formulations of tigecycline (2015-08-18),

5. 9085592 - Process for the preparation of fosamprenavir calcium (2015-07-21),

6. 9085556 - Salts of dexlansoprazole and their preparation (2015-07-21),

7. 9078830 - Multi-layered, multiple unit pharmaceutical compositions (2015-07-14),

8. 9000150 - Process for the preparation of pure meropenem trihydrate (2015-04-07),

9. 8916716 - Process for the preparation of crystalline form II of L-malic acid salt of sunitinib (2014-12-23),

10. 8916713 - Process for the preparation of febuxostat (2014-12-23),

11. 8911787 - Stable oral benzimidazole compositions and process of preparation thereof (2014-12-16),

12. 8871932 - Process for the preparation of tadalafil (2014-10-28),

13. 8853453 - Processes for reducing impurities in lacosamide (2014-10-07),

14. 8853411 - Process for the preparation of dexlansoprazole (2014-10-07),

15. 8846910 - Matrix metalloproteinase inhibitors (2014-09-30),

Ranbaxy Laboratories, Inc., headquartered in New Delhi, specializes in the development and manufacturing of pharmaceutical formulations. The company focuses on a range of core technology topics, including pharmaceutical compositions and stable formulations. Its research encompasses innovative drug delivery systems and the development of crystalline forms of active ingredients. Ranbaxy is recognized for its contributions to therapeutic areas such as antimicrobial agents and matrix metalloproteinase inhibitors, enhancing treatment options for various medical conditions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Ranbaxy Laboratories, Inc.

157 Patents

#3 in New Delhi

#12 in India

#5,222 in the World

New Delhi, India

Ranbaxy Laboratories, Inc.

Forward Citations = 461

253 inventors:

Yatendra Kumar (36 out of 37 patents)

Mohan Prasad (30 out of 43 patents)

Anita Mehta (21 out of 23 patents)

4. Rajesh Kumar Thaper (16 out of 17 patents)

5. Jag Mohan Khanna (15 out of 15 patents)

Please report any incorrect information to [email protected]

Loading…